MANILA, Reason 5 O O
PHILIPPINES Reason 5 O O
(11 Reason 5 O O
December Reason 5 O O
2020) Reason 5 O O
— Reason 5 O O
The Reason 5 O O
Asian Reason 5 O O
Development Reason 5 O O
Bank Reason 5 O O
(ADB) Reason 5 O O
has Reason 5 O O
launched Reason 5 O O
a Reason 5 O O
$9 Reason 5 O O
billion Reason 5 O O
vaccine Reason 5 O O
initiative—the Reason 5 O O
Asia Reason 5 O O
Pacific Reason 5 O O
Vaccine Reason 5 O O
Access Reason 5 O O
Facility Reason 5 O O
(APVAX)—offering Reason 5 O O
rapid Reason 5 O O
and Reason 5 O O
equitable Reason 5 O O
support Reason 5 O O
to Reason 5 O O
its Reason 5 O O
developing Reason 5 O O
member Reason 5 O O
countries Reason 5 O O
(DMCs) Reason 5 O O
as Reason 5 O O
they Reason 5 O O
procure Reason 5 O O
and Reason 5 O O
deliver Reason 5 O O
effective Reason 5 O O
and Reason 5 O O
safe Reason 5 O O
coronavirus Reason 5 O O
disease Reason 5 O O
(COVID-19) Reason 5 O O
vaccines. Reason 5 O O
"As Reason 5 O O
ADB's Reason 5 O O
DMCs Reason 5 O O
prepare Reason 5 O O
to Reason 5 O O
vaccinate Reason 5 O O
their Reason 5 O O
people Reason 5 O O
as Reason 5 O O
soon Reason 5 O O
as Reason 5 O O
possible, Reason 5 O O
they Reason 5 O O
need Reason 5 O O
financing Reason 5 O O
to Reason 5 O O
procure Reason 5 O O
vaccines Reason 5 O O
as Reason 5 O O
well Reason 5 O O
as Reason 5 O O
appropriate Reason 5 O O
plans Reason 5 O O
and Reason 5 O O
knowledge Reason 5 O O
to Reason 5 O O
be Reason 5 O O
able Reason 5 O O
to Reason 5 O O
safely, Reason 5 O O
equitably, Reason 5 O O
and Reason 5 O O
efficiently Reason 5 O O
manage Reason 5 O O
the Reason 5 O O
vaccination Reason 5 O O
process," Reason 5 O O
[said Reason 5 O O
ADB Reason 5 O O
President Reason 5 O O
Masatsugu Reason 5 O O
Asakawa](/news/videos/adb-announces-9-billion-covid-19-vaccine-initiative-developing-asia). Reason 5 O O
"APVAX Reason 5 O O
will Reason 5 O O
play Reason 5 O O
a Reason 5 O O
critical Reason 5 O O
role Reason 5 O O
in Reason 5 O O
helping Reason 5 O O
our Reason 5 O O
DMCs Reason 5 O O
meet Reason 5 O O
these Reason 5 O O
challenges, Reason 5 O O
overcome Reason 5 O O
the Reason 5 O O
pandemic, Reason 5 O O
and Reason 5 O O
focus Reason 5 O O
on Reason 5 O O
economic Reason 5 O O
recovery." Reason 5 O O
More O O O O
than O O O O
14.3 O O O O
million O O O O
positive O O O O
cases O O O O
have O O O O
been O O O O
identified O O O O
in O O O O
Asia O O O O
and O O O O
the O O O O
Pacific, O O O O
causing O O O O
more O O O O
than O O O O
200,000 O O O O
deaths. O O O O
As O O O O
the O O O O
pandemic O O O O
persists, O O O O
economic O O O O
growth O O O O
in O O O O
developing O O O O
Asia O O O O
is O O O O
[projected O O O O
to O O O O
contract O O O O
by O O O O
0.4% O O O O
in O O O O
2020](/news/developing-asia-contract-2020-grow-2021)—the O O O O
first O O O O
regional O O O O
gross O O O O
domestic O O O O
product O O O O
contraction O O O O
since O O O O
the O O O O
early O O O O
1960s. O O O O
Promoting Reason 5 O O
safe, Reason 5 O O
equitable, Reason 5 O O
and Reason 5 O O
effective Reason 5 O O
access Reason 5 O O
to Reason 5 O O
vaccines Reason 5 O O
is Reason 5 O O
a Reason 5 O O
top Reason 5 O O
priority Reason 5 O O
for Reason 5 O O
ADB's Reason 5 O O
COVID-19 Reason 5 O O
response Reason 5 O O
efforts. Reason 5 O O
Vaccination Reason 5 O O
programs Reason 5 O O
can Reason 5 O O
break Reason 5 O O
the Reason 5 O O
chain Reason 5 O O
of Reason 5 O O
virus Reason 5 O O
transmission, Reason 5 O O
save Reason 5 O O
lives, Reason 5 O O
and Reason 5 O O
mitigate Reason 5 O O
the Reason 5 O O
negative Reason 5 O O
economic Reason 5 O O
impacts Reason 5 O O
of Reason 5 O O
the Reason 5 O O
pandemic Reason 5 O O
by Reason 5 O O
restoring Reason 5 O O
confidence Reason 5 O O
in Reason 5 O O
people's Reason 5 O O
ability Reason 5 O O
to Reason 5 O O
work, Reason 5 O O
travel, Reason 5 O O
and Reason 5 O O
socialize Reason 5 O O
safely. Reason 5 O O
The O O O O
APVAX O O O O
provides O O O O
a O O O O
comprehensive O O O O
framework O O O O
and O O O O
resource O O O O
envelope O O O O
for O O O O
supporting O O O O
developing O O O O
Asia's O O O O
vaccine O O O O
access, O O O O
using O O O O
two O O O O
complementary O O O O
components. O O O O
The O O O O
Rapid O O O O
Response O O O O
Component O O O O
will O O O O
provide O O O O
timely O O O O
support O O O O
for O O O O
critical O O O O
vaccine O O O O
diagnostics, O O O O
procurement O O O O
of O O O O
vaccines, O O O O
and O O O O
transporting O O O O
vaccines O O O O
from O O O O
the O O O O
place O O O O
of O O O O
purchase O O O O
to O O O O
ADB's O O O O
DMCs. O O O O
The O O O O
Project O O O O
Investment O O O O
Component O O O O
will O O O O
support O O O O
investments O O O O
in O O O O
systems O O O O
for O O O O
successful O O O O
distribution, O O O O
delivery, O O O O
and O O O O
administration O O O O
of O O O O
vaccines O O O O
along O O O O
with O O O O
associated O O O O
investments O O O O
in O O O O
building O O O O
capacity, O O O O
community O O O O
outreach, O O O O
and O O O O
surveillance. O O O O
This O O O O
may O O O O
include O O O O
such O O O O
areas O O O O
as O O O O
cold-chain O O O O
storage O O O O
and O O O O
transportation, O O O O
vehicles, O O O O
distribution O O O O
infrastructure, O O O O
processing O O O O
facilities, O O O O
and O O O O
other O O O O
physical O O O O
investments. O O O O
The O O O O
component O O O O
may O O O O
also O O O O
be O O O O
used O O O O
to O O O O
develop O O O O
or O O O O
expand O O O O
vaccine O O O O
manufacturing O O O O
capacity O O O O
in O O O O
DMCs. O O O O
ADB O O O O
financing O O O O
for O O O O
vaccines O O O O
will O O O O
be O O O O
provided O O O O
in O O O O
close O O O O
coordination O O O O
with O O O O
other O O O O
development O O O O
partners O O O O
including O O O O
the O O O O
World O O O O
Bank O O O O
Group, O O O O
World O O O O
Health O O O O
Organization O O O O
(WHO), O O O O
COVID-19 O O O O
Vaccines O O O O
Global O O O O
Access O O O O
Facility O O O O
(COVAX), O O O O
GAVI, O O O O
and O O O O
bilateral O O O O
and O O O O
multilateral O O O O
partners. O O O O
APVAX O O O O
promotes O O O O
safe O O O O
and O O O O
effective O O O O
vaccines O O O O
to O O O O
be O O O O
accessed O O O O
in O O O O
a O O O O
fair O O O O
manner. O O O O
For Reason 3 O O
a Reason 3 O O
vaccine Reason 3 O O
to Reason 3 O O
be Reason 3 O O
eligible Reason 3 O O
for Reason 3 O O
financing, Reason 3 O O
it Reason 3 O O
must Reason 3 O O
meet Reason 3 O O
one Reason 3 O O
of Reason 3 O O
three Reason 3 O O
criteria. Reason 3 O O
It Reason 3 O O
must Reason 3 O O
be Reason 3 O O
procured Reason 3 O O
via Reason 3 O O
COVAX, Reason 3 O O
prequalified Reason 3 O O
by Reason 3 O O
WHO, Reason 3 O O
or Reason 3 O O
authorized Reason 3 O O
by Reason 3 O O
a Reason 3 O O
Stringent Reason 3 O O
Regulatory Reason 3 O O
Authority. Reason 3 O O
Additional Reason 3 O O
access Reason 3 O O
criteria, Reason 3 O O
such Reason 3 O O
as Reason 3 O O
a Reason 3 O O
vaccination Reason 3 O O
needs Reason 3 O O
assessment, Reason 3 O O
a Reason 3 O O
vaccine Reason 3 O O
allocation Reason 3 O O
plan Reason 3 O O
by Reason 3 O O
the Reason 3 O O
DMC, Reason 3 O O
and Reason 3 O O
a Reason 3 O O
mechanism Reason 3 O O
for Reason 3 O O
effective Reason 3 O O
coordination Reason 3 O O
among Reason 3 O O
development Reason 3 O O
partners Reason 3 O O
also Reason 3 O O
help Reason 3 O O
ensure Reason 3 O O
that Reason 3 O O
vaccine Reason 3 O O
support Reason 3 O O
under Reason 3 O O
APVAX Reason 3 O O
can Reason 3 O O
be Reason 3 O O
fairly Reason 3 O O
and Reason 3 O O
effectively Reason 3 O O
implemented. Reason 3 O O
ADB O O O O
is O O O O
also O O O O
making O O O O
available O O O O
a O O O O
$500 O O O O
million O O O O
Vaccine O O O O
Import O O O O
Facility O O O O
to O O O O
support O O O O
the O O O O
efforts O O O O
of O O O O
its O O O O
DMCs O O O O
to O O O O
secure O O O O
safe O O O O
and O O O O
effective O O O O
vaccines, O O O O
as O O O O
well O O O O
as O O O O
the O O O O
goods O O O O
that O O O O
support O O O O
distribution O O O O
and O O O O
inoculation. O O O O
The O O O O
facility O O O O
is O O O O
part O O O O
of O O O O
ADB's O O O O
Trade O O O O
and O O O O
Supply O O O O
Chain O O O O
Finance O O O O
Program. O O O O
AAA-guarantees O O O O
available O O O O
through O O O O
the O O O O
program's O O O O
vaccine O O O O
import O O O O
facility O O O O
will O O O O
mitigate O O O O
payment O O O O
risks O O O O
and O O O O
facilitate O O O O
import O O O O
of O O O O
these O O O O
goods. O O O O
This O O O O
will O O O O
employ O O O O
the O O O O
same O O O O
eligibility O O O O
criteria O O O O
on O O O O
vaccines O O O O
as O O O O
COVAX. O O O O
Cofinancing O O O O
with O O O O
private O O O O
sector O O O O
partners O O O O
could O O O O
result O O O O
in O O O O
the O O O O
Import O O O O
Facility O O O O
supporting O O O O
$1 O O O O
billion O O O O
in O O O O
vaccine O O O O
and O O O O
related O O O O
imports O O O O
within O O O O
a O O O O
year. O O O O
In O O O O
April, O O O O
ADB O O O O
approved O O O O
a O O O O
[$20 O O O O
billion O O O O
package](/news/adb-triples-covid-19-response-package-20-billion) O O O O
to O O O O
support O O O O
its O O O O
DMCs O O O O
in O O O O
addressing O O O O
the O O O O
impacts O O O O
of O O O O
the O O O O
pandemic O O O O
and O O O O
streamlined O O O O
some O O O O
procedures O O O O
to O O O O
deliver O O O O
quicker O O O O
and O O O O
more O O O O
flexible O O O O
assistance. O O O O
ADB O O O O
has O O O O
committed O O O O
$14.9 O O O O
billion O O O O
in O O O O
loans, O O O O
grants, O O O O
and O O O O
technical O O O O
assistance, O O O O
including O O O O
$9.9 O O O O
billion O O O O
in O O O O
quick-disbursing O O O O
budget O O O O
support O O O O
from O O O O
the O O O O
COVID-19 O O O O
Pandemic O O O O
Response O O O O
Option O O O O
(CPRO) O O O O
and O O O O
support O O O O
for O O O O
the O O O O
private O O O O
sector. O O O O
In O O O O
November, O O O O
ADB O O O O
announced O O O O
[$20.3 O O O O
million O O O O
in O O O O
additional O O O O
technical O O O O
assistance](/news/adb-allocates-20-million-help-developing-members-access-vaccines-covid-19) O O O O
to O O O O
establish O O O O
systems O O O O
to O O O O
enable O O O O
efficient O O O O
and O O O O
equitable O O O O
distribution O O O O
of O O O O
vaccines O O O O
across O O O O
Asia O O O O
and O O O O
the O O O O
Pacific. O O O O
ADB O O O O
is O O O O
committed O O O O
to O O O O
achieving O O O O
a O O O O
prosperous, O O O O
inclusive, O O O O
resilient, O O O O
and O O O O
sustainable O O O O
Asia O O O O
and O O O O
the O O O O
Pacific, O O O O
while O O O O
sustaining O O O O
its O O O O
efforts O O O O
to O O O O
eradicate O O O O
extreme O O O O
poverty. O O O O
Established O O O O
in O O O O
1966, O O O O
it O O O O
is O O O O
owned O O O O
by O O O O
68 O O O O
members—49 O O O O
from O O O O
the O O O O
region O O O O
